Filing Signals

Source: SEC EDGAR Compiled 2026-11-14 10:32 UTC 23 automated checks passing

← All events

Niki BioSolutions, Inc.

CIK 1734005 NIKI·Manufacturing · All EDGAR filings ↗

Progression

  1. Accounting standard newly cited 20-F
  2. Finance chief departure 8-K +200d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Finance chief departure high Filing comparison

Niki BioSolutions, Inc.'s Chief Financial Officer departed, with the filing citing for cause

Evidence
Adverse language
for cause
Interim only
No
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
high
Source
SEC 8-K item code
Successor named
Yes
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗

Accounting standard newly cited Filing comparison

Aptorum Group Ltd cited accounting standard ASU 2023-09 for the first time in this filing series

The Group adopted ASU 2023-09 from January 1, 2025 on a retrospective basis.
Evidence
Adopted
2023-09
Adoption year stated
2025
Contexts
The Group adopted ASU 2023-09 from January 1, 2025 on a retrospective basis.
New standards
2023-09
Prior filed
2025-04-30
Prior form
20-F
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.
Formerly
Aptorum Group Ltd

Source filing ↗ Prior filing ↗